Bridgeway Capital Management, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.15 - $7.2 $3,675 - $176,400	-24,500 Reduced 9.82%	224,900 $38,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.58 $14,400 - $34,800	-60,000 Reduced 19.39%	249,400 $67,000
Q4 2021 Feb 14, 2022	BUY	$0.62 - $1.61 $135,160 - $350,980	218,000 Added 238.51%	309,400 $217,000
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.0 $70,272 - $115,200	-57,600 Reduced 38.66%	91,400 $149,000
Q2 2021 Aug 16, 2021	SELL	$1.35 - $3.36 $29,430 - $73,248	-21,800 Reduced 12.76%	149,000 $297,000
Q4 2020 Feb 16, 2021	SELL	$2.42 - $4.48 $12,100 - $22,400	-5,000 Reduced 2.84%	170,800 $680,000
Q2 2020 Aug 14, 2020	BUY	$1.56 - $3.65 $124,644 - $291,635	79,900 Added 83.32%	175,800 $533,000
Q1 2020 May 15, 2020	SELL	$1.96 - $7.96 $58,800 - $238,800	-30,000 Reduced 23.83%	95,900 $188,000
Q4 2019 Feb 14, 2020	BUY	$3.19 - $7.56 $401,621 - $951,804	125,900 New	125,900 $927,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.